Skip to main content
SpringerLink
Log in

Growth Factor Therapy

  • Chapter
Innovations and Advances in Wound Healing

Abstract

Many of the chronic wounds are delayed or fail to heal through conventional treatment because attenuated activities of cells responsible for wound healing contribute to the impairment of tissue restoration. The orderly and efficient progression of the wound healing sequence is orchestrated by intercellular communication, much of which is regulated by growth factors and cytokines. Consequently, there is a need for more effective therapy that will stimulate cellular activity of chronic wound patients. Recently, there has been much interest in treating these ulcers with various types of treatment modalities to stimulate cellular functions of chronic wound patients, including growth factors and cell therapies. It has long been hypothesized that using growth factors can promote healing of chronic wounds. Research is currently under way on methods to externally deliver growth factors depleted by diminished cell function in chronic wounds which would therefore facilitate healing; some of these are already being used in clinical settings. Products containing platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF) for topical use on diabetic foot ulcers are some examples. In this chapter, various growth factor therapies that are used clinically to increase cell activities are described.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Akasaka Y, Ono I, Yamashita T, et al. Basic fibroblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds. J Pathol. 2004;203:710–20.

    Article  CAS  PubMed  Google Scholar 

  • Akasaka Y, Ono I, Kamiya T, et al. The mechanisms underlying fibroblast apoptosis regulated by growth factors during wound healing. J Pathol. 2010;221:285–99.

    Article  CAS  PubMed  Google Scholar 

  • Akita S, Akino K, Imaizumi T, Hirano A. A basic fibroblast growth factor improved the quality of skin grafting in burn patients. Burns. 2005;31:855–8.

    Article  PubMed  Google Scholar 

  • Akita S, Akino K, Imaizumi T, et al. The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor. J Burn Care Res. 2006;27:333–8.

    Article  PubMed  Google Scholar 

  • Akita S, Akino K, Imaizumi T, Hirano A. Basic fibroblast growth factor accelerates and improves second-degree burn wound healing. Wound Repair Regen. 2008;16:635–41.

    Article  PubMed  Google Scholar 

  • Barnham KJ, Torres AM, Alewood D, et al. Role of the 6–20 disulfide bridge in the structure and activity of epidermal growth factor. Protein Sci. 1998;7:1738–49.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem. 1990;265:7709–12.

    CAS  PubMed  Google Scholar 

  • Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962;237:1555–62.

    CAS  PubMed  Google Scholar 

  • Dawson JP, Berger MB, Lin CC, et al. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol Cell Biol. 2005;25:7734–42.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Dreux AC, Lamb DJ, Modjtahedi H, Ferns GA. The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis. Atherosclerosis. 2006;186:38–53.

    Article  CAS  PubMed  Google Scholar 

  • Eto H, Suga H, Aoi N, et al. Therapeutic potential of fibroblast growth factor-2 for hypertrophic scars: upregulation of MMP-1 and HGF expression. Lab Invest. 2012;92:214–23.

    Article  CAS  PubMed  Google Scholar 

  • Fallon JH, Seroogy KB, Loughlin SE, et al. Epidermal growth factor immunoreactive material in the central nervous system: location and development. Science. 1984;224:1107–9.

    Article  CAS  PubMed  Google Scholar 

  • Fernández-Montequín JI, Infante-Cristiá E, Valenzuela-Silva C, et al. Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation. Int Wound J. 2007;4:333–43.

    PubMed  Google Scholar 

  • Gospodarowicz D. Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature. 1974;249:123–7.

    Article  CAS  PubMed  Google Scholar 

  • Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res. 2003a;284:2–13.

    Article  CAS  PubMed  Google Scholar 

  • Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res. 2003b;284:2–13.

    Article  CAS  PubMed  Google Scholar 

  • Hebda PA, Klingbeil CK, Abraham JA, Fiddes JC. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol. 1990;95:626–31.

    Article  CAS  PubMed  Google Scholar 

  • Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys. 2004;59:21–6.

    Article  CAS  PubMed  Google Scholar 

  • Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Ann Plast Surg. 2006;56:394–8.

    Article  CAS  PubMed  Google Scholar 

  • Kanda N, Morimoto N, Takemoto S, et al. Efficacy of novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor for dermis-like tissue regeneration. Ann Plast Surg. 2012;69:569–74.

    Article  CAS  PubMed  Google Scholar 

  • Kanda N, Morimoto N, Ayvazyan AA, et al. Evaluation of a novel collagen-gelatin scaffold for achieving the sustained release of basic fibroblast growth factor in a diabetic mouse model. J Tissue Eng Regen Med. 2014;8:29–40.

    Article  CAS  PubMed  Google Scholar 

  • Kawaguchi H, Jingushi S, Izumi T, et al. Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose-escalation prospective trial on patients with osteotomy. J Orthop Res. 2007;25:480–7.

    Article  CAS  PubMed  Google Scholar 

  • Kawai K, Suzuki S, Tabata Y, et al. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials. 2000;21:489–99.

    Article  CAS  PubMed  Google Scholar 

  • Kitamura M, Akamatsu M, Machigashira M, et al. FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial. J Dent Res. 2011;90:35–40.

    Article  CAS  PubMed  Google Scholar 

  • Kusuhara H, Itani Y, Isogai N, Tabata Y. Randomized controlled trial of the application of topical b-FGF impregnated gelatin microspheres to improve tissue survival in subzone II fingertip amputations. J Hand Surg Eur. 2011;36:455–60.

    Article  Google Scholar 

  • Lurje G, Lenz HJ. EGFR signaling and drug discovery. Oncology. 2009;77:400–10.

    Article  CAS  PubMed  Google Scholar 

  • Margolis DJ, Bartus C, Hoffstad O, et al. Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers. Wound Repair Regen. 2005;13:531–6.

    Article  PubMed  Google Scholar 

  • McGee GS, Davidson JM, Buckley A, et al. Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res. 1988;45:145–53.

    Article  CAS  PubMed  Google Scholar 

  • Ortega S, Ittmann M, Tsang SH, et al. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A. 1998;95:5672–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974;71:1207–10.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Senet P, Vicaut E, Beneton N, et al. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial. Arch Dermatol. 2011;147:926–30.

    Article  CAS  PubMed  Google Scholar 

  • Stortelers C, Souriau C, van Liempt E, et al. Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display. Biochemistry. 2002;41:8732–41.

    Article  CAS  PubMed  Google Scholar 

  • Tsuboi R, Rifkin DB. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med. 1990;172:245–51.

    Article  CAS  PubMed  Google Scholar 

  • Tuyet HL, Nguyen Quynh TT, Vo Hoang Minh H, et al. The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary results. Int Wound J. 2009;6:159–66.

    Article  PubMed  Google Scholar 

  • Uemura T, Watanabe H, Uemura Y. Clinical use of Trafermin (fiblast spray) in pediatric outpatients with burn injuries. Jpn J Burn Inj. 2006;32:291–7.

    Google Scholar 

  • Urist MR. Bone: formation by auto induction. Science. 1695;150:893–9.

    Article  Google Scholar 

  • Venturi S, Venturi M. Iodine in evolution of salivary glands and in oral health. Nutr Health. 2009;20:119–34.

    Article  CAS  PubMed  Google Scholar 

  • Wong L, Deb TB, Thompson SA, et al. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling. J Biol Chem. 1999;274:8900–9.

    Article  CAS  PubMed  Google Scholar 

  • Yao C, Yao P, Wu H, Zha Z. Acceleration of wound healing in traumatic ulcers by absorbable collagen sponge containing recombinant basic fibroblast growth factor. Biomed Mater. 2006;1:33–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Professor of Plastic Surgery, Director of Diabetic Wound Center, Director of Cell Therapy Laboratory, Korea University College of Medicine and Korea University Guro Hospital, Seoul, Republic of Korea (South Korea)

    Seung-Kyu Han

Authors
  1. Seung-Kyu Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Han, SK. (2016). Growth Factor Therapy. In: Innovations and Advances in Wound Healing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46587-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-46587-5_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-46586-8

  • Online ISBN: 978-3-662-46587-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation